Rocket Pharmaceuticals
RCKT
RCKT
168 hedge funds and large institutions have $1.46B invested in Rocket Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 77 increasing their positions, 41 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% more funds holding
Funds holding: 164 → 168 (+4)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
8.2% less ownership
Funds ownership: 104.58% → 96.38% (-8.2%)
Holders
168
Holding in Top 10
3
Calls
$18.9M
Puts
$3.6M
Top Buyers
| 1 | +$36.9M | |
| 2 | +$29.9M | |
| 3 | +$21.4M | |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
+$16.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$16.4M |
Top Sellers
| 1 | -$20.2M | |
| 2 | -$19.7M | |
| 3 | -$13.9M | |
| 4 |
Morgan Stanley
New York
|
-$13M |
| 5 |
HM
HealthCor Management
New York
|
-$7.73M |